Shape complexity in drug candidates linked to clinical success

Shape complexity in drug candidates linked to clinical success
Image: Intellect (generated)

In short: Researchers studied compounds from drug-discovery pipelines and devised two simple measures of three-dimensional molecular complexity: how saturated a molecule's carbon skeleton is, and whether it contains a chiral carbon. Compounds scoring higher on both measures were more likely to progress from early discovery through clinical testing into approved drugs.

The work reflects growing attention among chemists to simple physical properties - like size and ring structure - that influence whether a drug candidate succeeds. The authors suggest high-throughput synthesis methods may have pushed discovery toward flatter, ring-heavy molecules, and found that more three-dimensional, saturated compounds also tended to dissolve more easily, a property that matters for a drug to work in the body.

These patterns come from comparing chemical properties across past drug candidates at different development stages, not from a trial that directly tested whether added complexity improves a drug's chances.

Why it matters: A molecule's three-dimensional shape may be a subtle but overlooked factor in whether it eventually becomes a successful drug.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/technology-research-increasing-molecular-complexity-may-help-drug-candidates-mov.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…